Headline
The latest stories from AHA Today.
German biotech firm CureVac N.V. announced interim data from its ongoing Phase 1 dose-escalation study evaluating its CVnCoV SARS-CoV-2 vaccine candidate for safety, reactogenicity and immunogenicity.
Specialty drugs more than doubled as a share of retail fills for the overall U.S. population between 2010 and 2017, according to a study using various sources and published in Health Affairs, growing from 1% to 2.3%.
The Center for Medicare and Medicaid Innovation Oct. 30 announced the participation of 51 Direct Contracting Entities in the implementation period of the Global and Professional Options of the Direct Contracting Model.
The Centers for Medicare & Medicaid Services Nov. 1 approved Georgia’s waiver allowing the state to forgo a government-run website to help individuals enroll in coverage, instead relying on private brokers and insurers.
The Centers for Disease Control and Prevention recently released a new resource highlighting core components of environmental cleaning disinfection in hospitals.
The AHA provided comments on the Centers for Medicare & Medicaid Services’ proposed revision to the definition of “reasonable and necessary” for purposes of Medicare coverage determinations.
AHA President and CEO Rick Pollack recently spoke with Modern Healthcare about a host of issues, including COVID-19, the future of the Affordable Care Act and the importance of preserving coverage, and what issues are at stake for hospitals and health systems during a lame-duck session of Congress.
The Centers for Medicare & Medicaid Services Oct. 30 released Part II of the calendar year 2022 Medicare Advantage and Part D Advance Notice.
The departments of Health and Human Services and Defense this weekend announced a pair of contracts to expand domestic COVID-19 testing capacity.
The Food and Drug Administration, Customs and Border Protection, and Immigration and Customs Enforcement Oct. 30 announced a memorandum of understanding to maximize inspection and detection capabilities in order to prevent harmful products from entering the U.S. through international mail…